Posted by TechCrunch on July 31, 2019 09:23:46In a world where health care is so fragmented and expensive, a new generation of medical specialists is beginning to emerge.
They’re looking to harness the energy of nuclear medicine to help people live longer and healthier lives.
A team of researchers led by Dr. Richard Tipton, Director of the Cancer Center at the University of Washington in Seattle, hopes to unlock the secrets of aging and cancer by using the new technology to treat cancers like cancer and diabetes, among other ailments.
“A lot of our cancers are due to a mutation in our DNA that is passed on through a parent,” said Dr. Tiptons senior scientist, Dr. Jennifer Kuzawa, in a press release.
“If we can cure that mutation and remove it from our cells, we could really save lives.”
“If we cure that cancer, we would have a cure for almost any other cancer,” said Tiptone.
The research team’s new technology has been approved for clinical trials by the US Food and Drug Administration (FDA).
A phase one clinical trial is underway in Seattle.
Tiptons research team is working to make nuclear medicine treatments more affordable for patients.
A portion of the profits from the commercialization of nuclear treatments would go to a nonprofit, which in turn would be used to help support research into more effective treatments.
In an interview with TechCrunch, Dr Kuzowa said the team was excited about being able to use the power of nuclear medicines to treat cancer, as well as other diseases.
“We’re working to develop a treatment that can be used for patients who have very aggressive cancer, for example,” said Kuzowsa.
“We are looking at treatments for chronic obstructive pulmonary disease, for which there is no known cure.”
Tipton and his team have been studying the effects of nuclear treatment on cancer patients for about three years.
They’ve found that, when combined with other medical therapies, they’re able to increase the survival rates of patients who had been on cancer medications.
“Our patients who were on chemotherapy or radiation therapy, were almost completely cured by using this new technology,” said the director.
“In other words, if we can treat the cancer, then we can give the patient a cure.”
Dr. Tippon said that, in general, a cancer patient would need to take between two and four medications a day to achieve a healthy lifespan.
“The drugs in our trial were actually pretty effective for about 75 percent of the patients,” said Thelma Kuzawas, a clinical director of the team.
“For the rest, we had to take two to three medications a month.
We did this to get a better picture of the benefits of this technology and the side effects of it.”
Thelma and Dr. Kuzowas believe that their work will lead to new treatments for patients with cancers, such as those that occur in the brain and spinal cord.
“There are a lot of people that are living in a state of limbo,” said Ingrid Tiptones research director.
She said that it’s time for a new paradigm.
“When we think about curing cancer, there’s a lot to be done,” said Forlizzo.
“What is going to be a cure?
We want to make sure that we don’t make things worse, but we also want to keep people alive.”
Forlizzos work to cure diabetes and cancer, while developing other treatments for other diseases like diabetes and cardiovascular disease.
Thelms cancer research is funded by the Howard Hughes Medical Institute.